 |
PDBsum entry 4p4k
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4p4k
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
178 a.a.
|
 |
|
|
|
|
|
|
|
199 a.a.
|
 |
|
|
|
|
|
|
|
204 a.a.
|
 |
|
|
|
|
|
|
|
241 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Structural basis of chronic beryllium disease: bridging the gap between allergic hypersensitivity and auto immunity
|
|
Structure:
|
 |
Hla class ii histocompatibility antigen, dp alpha 1 chain. Chain: a, e. Fragment: unp residues 32-214. Synonym: dp(w3),dp(w4),hla-sb alpha chain,mhc class ii dp3-alpha,mhc class ii dpa1. Engineered: yes. Mim2 peptide,hla class ii histocompatibility antigen, dp beta 1 chain. Chain: b, f.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-dpa1, hla-dp1a, hlasb. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469. Gene: hla-dpb1, hla-dp1b. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.206
|
R-free:
|
0.252
|
|
|
Authors:
|
 |
G.M.Clayton,F.Crawford,J.W.Kappler
|
|
Key ref:
|
 |
G.M.Clayton
et al.
(2014).
Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.
Cell,
158,
132-142.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Mar-14
|
Release date:
|
16-Jul-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P20036
(DPA1_HUMAN) -
HLA class II histocompatibility antigen, DP alpha 1 chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
260 a.a.
178 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P04440
(DPB1_HUMAN) -
HLA class II histocompatibility antigen, DP beta 1 chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
258 a.a.
199 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
158:132-142
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.
|
|
G.M.Clayton,
Y.Wang,
F.Crawford,
A.Novikov,
B.T.Wimberly,
J.S.Kieft,
M.T.Falta,
N.A.Bowerman,
P.Marrack,
A.P.Fontenot,
S.Dai,
J.W.Kappler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
T-cell-mediated hypersensitivity to metal cations is common in humans. How the
T cell antigen receptor (TCR) recognizes these cations bound to a major
histocompatibility complex (MHC) protein and self-peptide is unknown.
Individuals carrying the MHCII allele, HLA-DP2, are at risk for chronic
beryllium disease (CBD), a debilitating inflammatory lung condition caused by
the reaction of CD4 T cells to inhaled beryllium. Here, we show that the
T cell ligand is created when a Be(2+) cation becomes buried in an
HLA-DP2/peptide complex, where it is coordinated by both MHC and peptide acidic
amino acids. Surprisingly, the TCR does not interact with the Be(2+) itself, but
rather with surface changes induced by the firmly bound Be(2+) and an
accompanying Na(+) cation. Thus, CBD, by creating a new antigen by indirectly
modifying the structure of preexisting self MHC-peptide complex, lies on the
border between allergic hypersensitivity and autoimmunity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |